| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.4 | 0.03 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.33 | 0.03 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |